England’s NHS to Provide Artificial Pancreas for Diabetes Patients

By
Dr. Isabelle Moreau
1 min read

England’s National Health Service (NHS) has announced the distribution of an ‘artificial pancreas’ to tens of thousands of children and adults with type 1 diabetes, aimed at efficiently managing insulin levels. The system comprises a sensor under the skin that wirelessly communicates with an externally worn pump to deliver insulin as needed, eliminating the need for finger sticks or injections. This initiative sets a precedent in providing these devices free-of-charge through the publicly funded healthcare system. The hybrid closed-loop system requires some user input, such as entering carb intake, in an otherwise self-regulating process. The NHS plans to identify eligible patients for the program starting immediately, acknowledging the potential life-changing impact for the estimated 269,095 people in England with type 1 diabetes. Colette Marshall, chief executive of Diabetes UK, emphasized the significant improvement in both health and quality of life for individuals with diabetes, marking it as a monumental moment in healthcare.

This article is submitted by our user under the News Submission Rules and Guidelines.The cover photo is computer generated art for illustrative purposes only; not indicative of factual content.

Subscribe to our Newsletter

Get the latest in enterprise business and tech with exclusive peeks at our new offerings